Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) DeferredTaxAndRevenue: E£0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:MCRO Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO
41 GF Score
Price E£1.68
! 3 Warning Signs
View Full Analysis

What is Macro Group Pharmaceuticals (Macro Capital) Co DeferredTaxAndRevenue?

Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO -1.75% 41 DeferredTaxAndRevenue is E£0.0 Mil as of Jun. 2026. GuruFocus rates CAI:MCRO with a GF Score™ of 41/100. The stock has 3 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Macro Group Pharmaceuticals (Macro Capital) Co's current deferred tax and revenue for the quarter that ended in Jun. 2026 was E£0.0 Mil.

Macro Group Pharmaceuticals (Macro Capital) Co DeferredTaxAndRevenue Related Terms

Macro Group Pharmaceuticals (Macro Capital) Co DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macro Group Pharmaceuticals (Macro Capital) Co DeferredTaxAndRevenue Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend Dec20 Dec21 Dec22
DeferredTaxAndRevenue
0.00 0.00 0.00

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CAI:MCRO
41GF Score
Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of E£0.0 Mil mean?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a DeferredTaxAndRevenue of E£0.0 Mil as of Jun. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co.
Is Macro Group Pharmaceuticals (Macro Capital) Co's DeferredTaxAndRevenue too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current DeferredTaxAndRevenue is E£0.0 Mil. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's DeferredTaxAndRevenue compare to PG and CL?
Macro Group Pharmaceuticals (Macro Capital) Co's DeferredTaxAndRevenue of E£0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Consumer Packaged Goods company?
A good DeferredTaxAndRevenue depends on the Consumer Packaged Goods industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co. Macro Group Pharmaceuticals (Macro Capital) Co's current DeferredTaxAndRevenue is E£0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current DeferredTaxAndRevenue of E£0.0 Mil. The current DeferredTaxAndRevenue is E£0.0 Mil. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current DeferredTaxAndRevenue is E£0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Macro Group Pharmaceuticals (Macro Capital) Co Business Description

Address 83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
41GF Score

Get the complete analysis for CAI:MCRO

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£1.68
Price